Autopsy report · NCT02117076
Blinded, Randomized Study of Gabapentin (Neurontin®) and Gabapentin Enacarbil (Horizant™) in Restless Leg Syndrome
Cause of deathSlow enrollment
“Recruitment unsuccessful due to overly restrictive inclusion/exclusion criteria.”
Life of this trial
- Ran for about 2 years 2 months before it stopped.
- 5 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Theresa Zesiewicz, MD
- Sponsor type
- University, hospital or other
- Conditions
- Restless Leg Syndrome
- Interventions
- Gabapentin immediate release; Gabapentin enacarbil extended release
- Participants
- 5
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Effects of Prismatic Spectacle Lenses on Symptoms of Dizziness, Headache and Anxiety as Caused by Vertical Heterophoria
“Unable to recruit - multiple reasons.- inclusion/exclusion criteria too strict was th emain reason.” - PANenteric Crohn's Capsule Versus Ileo-Colonoscopy and Scan Study
“Failed to meet recruitment target due to multitude of factors (strict eligibility criteria and lack of clinician and participant engagement)” - Cognitive-Behavioral Therapy (CBT) in Children With Diabetes
“Recruitment difficulties (study stopped before the expected 80 inclusions)” - Use of Patient-Controlled Analgesia in Acute Pancreatitis
“inadequate recruitment despite efforts” - RCVS: The Rational Approach to Diagnosis and Treatment
“Failure to recruit patients meeting inclusion criteria.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.